Controversial Issues on β-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy?
Despite the introduction of ACE-inhibitors and the consequent improvement in prognosis, mortality rates in patients with heart failure remain high, ranging from 10% to 40% depending on severity [1, 2]. Thus additional therapies are required to reduce the morbidity and mortality associated with heart failure.
KeywordsHeart Failure NYHA Class Conventional Medical Treatment North Scandinavian Enalapril Survival Study Cooperative North Scandinavian Enalapril Survival
Unable to display preview. Download preview PDF.
- 8.CIBIS Investigators and Committees (1994) A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study. Circulation 90:1765–1773Google Scholar
- 13.Eichhorn EJ, Bristow MR (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94:2285–2296Google Scholar